Correlation Between Virtus LifeSci and IShares Genomics

Can any of the company-specific risk be diversified away by investing in both Virtus LifeSci and IShares Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virtus LifeSci and IShares Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Virtus LifeSci Biotech and iShares Genomics Immunology, you can compare the effects of market volatilities on Virtus LifeSci and IShares Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virtus LifeSci with a short position of IShares Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virtus LifeSci and IShares Genomics.

Diversification Opportunities for Virtus LifeSci and IShares Genomics

0.72

Correlation Coefficient

Virtus LifeSci  IShares Genomics

Poor diversification

The 3 months correlation between Virtus and IShares is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Virtus LifeSci Biotech and iShares Genomics Immunology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Genomics Imm and Virtus LifeSci is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virtus LifeSci Biotech are associated (or correlated) with IShares Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Genomics Imm has no effect on the direction of Virtus LifeSci i.e., Virtus LifeSci and IShares Genomics go up and down completely randomly.

Pair Corralation between Virtus LifeSci and IShares Genomics

Considering the 90-day investment horizon Virtus LifeSci Biotech is expected to generate 1.15 times more return on investment than IShares Genomics. However, Virtus LifeSci is 1.15 times more volatile than iShares Genomics Immunology. It trades about -0.07 of its potential returns per unit of risk. iShares Genomics Immunology is currently generating about -0.12 per unit of risk. If you would invest  6,443  in Virtus LifeSci Biotech on September 20, 2024 and sell it today you would lose (467.00) from holding Virtus LifeSci Biotech or give up 7.25% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Virtus LifeSci Biotech  vs.  iShares Genomics Immunology

Virtus LifeSci Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Virtus LifeSci Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest unsteady performance, the Etf's fundamental drivers remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the ETF retail investors.

iShares Genomics Imm

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days iShares Genomics Immunology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Etf's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the ETF investors.

Pair Trading with Virtus LifeSci and IShares Genomics

The main advantage of trading using opposite Virtus LifeSci and IShares Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virtus LifeSci position performs unexpectedly, IShares Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Genomics will offset losses from the drop in IShares Genomics' long position.

The idea behind Virtus LifeSci Biotech and iShares Genomics Immunology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.